Objective: The objective of this study was to provide an overview of evidence regarding exercise therapies for patients with lower extremity peripheral artery disease (PAD).
Lower extremity peripheral artery disease (PAD) now affects 8.5 million people in the United States and >200 million worldwide. 1, 2 Whereas most people with PAD will not develop critical limb ischemia, people with PAD have greater functional impairment, more rapid functional decline, and faster mobility loss than those without PAD. [3] [4] [5] [6] [7] PAD-related functional impairment is associated with increased rates of hospitalization, nursing home placement, and mobility loss. [8] [9] [10] Identifying and implementing interventions to improve functional performance and to prevent functional decline are important priorities in the care of patients with PAD and intermittent claudication. Few medications have been identified that meaningfully improve walking performance in people with PAD. Only two medications, cilostazol and pentoxifylline, are Food and Drug Administration approved for treating PAD-associated walking impairment. Furthermore, benefits from cilostazol are modest. Cilostazol improves treadmill walking performance in people with PAD and intermittent claudication by approximately 25% to 40%. [11] [12] [13] Recently published clinical practice guidelines for PAD recommend against pentoxifylline because of lack of efficacy. 14 
SUPERVISED TREADMILL EXERCISE FOR PAD
A large body of evidence from randomized clinical trials demonstrates that supervised walking exercise significantly and substantially improves pain-free and maximal treadmill walking distance in people with PAD.
14- 16 Fakhry et al 16 published a meta-analysis of 25 randomized clinical trials of supervised walking exercise, including 1054 PAD patients with intermittent claudication. The 25 included studies were published between 1996 and 2012, ranged from 4 to 104 weeks in duration, and compared a supervised walking exercise intervention with a control group that did not receive an exercise intervention. Results demonstrated that supervised walking exercise was associated with a 180-meter greater increase in maximal treadmill walking distance compared with the control group. Supervised walking exercise was also associated with a 128-meter greater increase in pain-free treadmill walking distance compared with the control group. 16 In summary, randomized clinical trials consistently demonstrate that supervised treadmill exercise improves total treadmill walking distance and pain-free treadmill walking distance in people with PAD who have intermittent claudication. 16 Supervised treadmill exercise has also been shown to improve treadmill walking performance and 6-minute walk distance in PAD patients who have atypical ischemic leg symptoms other than intermittent claudication. 17 Despite its benefits, supervised treadmill exercise has been inaccessible to many PAD patients with intermittent claudication. Lack of access to supervised exercise among people with PAD and intermittent claudication is in part due to lack of medical insurance coverage. Before 2017, the Centers for Medicare and Medicaid Services (CMS) did not provide coverage for supervised exercise for people with PAD and intermittent claudication. Many private medical insurance companies also have not provided health care coverage for supervised treadmill exercise for patients with PAD. Without medical insurance coverage, many patients with PAD are not able to afford participation in supervised treadmill exercise programs. In addition, traveling to an exercise center three times weekly for supervised exercise is burdensome, especially for PAD patients who are older and have limited mobility. Even when supervised exercise is provided to PAD patients without costs, such as in a research program, many PAD patients decline participation. 18 A recent report summarized refusal rates by potential participants in 23 clinical trials of supervised exercise in people with PAD. Of 1541 potential participants without critical limb ischemia who had sufficient ischemic symptoms to be eligible for inclusion in supervised exercise studies, 769 (50%) reported lack of interest or simply refused participation in supervised exercise and an additional 295 (19%) reported that attending supervised exercise was too inconvenient. 18 Overall, 69% of eligible PAD participants refused participation in supervised exercise. In summary, this systematic review demonstrated that even when supervised exercise was available without cost to the participant with PAD, approximately two-thirds of people with PAD declined participation.
MEDICAL INSURANCE COVERAGE FOR SUPERVISED EXERCISE FOR INTERMITTENT CLAUDICATION
In early 2017, the CMS released a proposed decision memorandum regarding coverage of supervised exercise therapy for symptomatic PAD. 19 The memorandum stated that evidence is sufficient to cover supervised exercise therapy for beneficiaries who have PAD with symptoms of intermittent claudication. The memorandum further indicated that CMS was considering coverage of supervised exercise therapy that consisted of three exercise sessions per week of 30 to 60 minutes of exercise for up to 12 weeks. The exercise program proposed for coverage by CMS must be located in a hospital or outpatient hospital setting and delivered by qualified personnel trained in basic and advanced life support and also in exercise therapy for PAD. 19 The exercise program must be carried out under direct supervision by a physician. On May 30, 2017, CMS announced that they would provide coverage for supervised exercise for patients with symptomatic peripheral artery disease.
HOME-BASED WALKING EXERCISE FOR PAD
Home-based exercise programs have the potential to be more accessible and acceptable to patients with PAD than supervised exercise programs, which require travel to the medical center three times weekly and can be costly if medical insurance does not pay. However, until recently, home-based walking exercise was considered not effective for PAD patients. For example, 2006 American Heart Association/American College of Cardiology clinical practice guidelines concluded that there was no evidence to support advising people with PAD to "go home and walk." 20 This 2006 conclusion was based on several small studies of home-based exercise in PAD patients with claudication that did not incorporate behavioral change techniques. [21] [22] [23] Since 2011, three randomized clinical trials have demonstrated that home-based exercise can improve walking performance in people with PAD. [24] [25] [26] In the first of these randomized trials, Gardner et al 26 randomized 119 men and women with PAD and intermittent claudication to one of three groups for 12 weeks: supervised treadmill exercise, home-based walking exercise, or a control group. Participants randomized to supervised treadmill exercise attended exercise sessions three times weekly and walked for up to 40 minutes at each exercise session. Participants randomized to home-based exercise used activity monitors to monitor their home exercise and were instructed to walk three times per week at a selfselected pace, working up to 45 minutes of walking exercise per session. PAD participants were instructed to wear the step counter during exercise sessions and also to record their walking exercise activity on a log. Every 2 weeks, participants in the home-exercise group returned to the medical center, where they reviewed their walking exercise progress with a study investigator, using the activity monitor data and the exercise log. The investigator provided feedback and instructions for walking exercise for the next 2 weeks. At 12-week follow-up, the groups randomized to supervised treadmill exercise and homebased walking exercise each significantly improved their pain-free and maximal treadmill walking performance compared with the control group (Table I ). There were no significant differences in the degree of improvement in pain-free or maximal treadmill walking time between the supervised treadmill exercise group and the homebased exercise group. Neither exercise group improved their Walking Impairment Questionnaire score compared with the control group. Quality of life, measured by the 36-Item Short Form Health Survey physical functioning questionnaire, improved by 9 points in the supervised exercise group and by 8 points in the home-based exercise group. The change in the 36-Item Short Form Health Survey physical functioning score was statistically significant in the supervised exercise group compared with the control group but not in the home-based exercise group compared with the control group. 26 The trial had a 23% dropout rate overall and a 28% dropout rate in the home-based exercise group. The high dropout rate in the home-exercise group may represent difficulties with adherence to home-based exercise in people with PAD. In the second randomized trial, Gardner et al 24 randomized 180 participants with PAD and intermittent claudication to supervised treadmill exercise, homebased walking exercise, or an attention control light resistance training group for 12 weeks. Participants randomized to supervised exercise were asked to walk for exercise on the treadmill 3 days per week, working up to 40 minutes per session, and walking to maximal ischemic leg pain. Participants randomized to home exercise were asked to walk for exercise at a self-selected pace 3 days weekly, working up to 45 minutes per session. PAD participants in the home-exercise group used an exercise step monitor to track their walking exercise activity. PAD participants in the home-exercise group walked at a self-selected pace during exercise sessions. PAD participants in the home-based exercise program returned at 1-week follow-up and subsequently at 4-, 8-, and 12-week follow-up. At each follow-up session, a study investigator reviewed the exercise data measured by the step counter and provided feedback. Instructions were provided for exercise activity during the next 4 weeks. Participants randomized to the attention control group engaged in resistance training, predominantly involving the upper extremities. At 12-week follow-up, the supervised exercise group increased their maximal treadmill walking time by 192 seconds, the home-based walking exercise group increased their maximal treadmill walking time by 110 seconds, and the control group increased their walking time by 22 seconds (Table I) . 24 At 12 week follow-up, the supervised exercise group increased their pain-free treadmill walking time by 170 seconds, the home-based walking exercise group increased their pain-free treadmill walking time by 104 seconds, and the control group increased their pain-free walking time by 17 seconds (Table I) . At 12-week follow-up, distance achieved in the 6-minute walk increased by 15 meters in the supervised exercise group, by 45 meters in the home-based exercise group, and by 4 meters in the control group. Each exercise group improved the 6-minute walk distance significantly more than the control group. The supervised treadmill exercise group improved the peak treadmill walking time significantly more than the home-based exercise group, but the home-based exercise group improved the 6-minute walk significantly more than the supervised treadmill exercise group. This trial underscores the phenomenon in which treadmill walking exercise interventions that train participants on the treadmill achieve greater gains on the treadmill outcome measure, whereas home-based walking exercise interventions in which participants train by walking over ground achieve greater gains in the 6-minute walk test (ie, a corridor
Primary results Additional observations
The supervised treadmill exercise group improved their peak treadmill exercise time by 215 6 173 seconds, the homebased walking exercise group improved their peak treadmill walking time by 124 6 193 seconds, and the control group declined by 10 seconds. Each exercise group also improved their time to treadmill onset of claudication (þ165 seconds, þ134 seconds, À16 seconds, respectively). Improvements in each exercise group were statistically significant compared with the control group, but the exercise groups were not significantly different from each other.
There was a 23% dropout rate overall. The Walking Impairment Questionnaire score did not significantly change in each exercise group compared with the control group.
The supervised treadmill exercise group improved their peak treadmill exercise time by 192 6 190 seconds, the homebased walking exercise group improved their peak treadmill walking time by 110 6 193 seconds, and the control group declined by 22 6 159 seconds. Each exercise group also improved the time to onset of claudication pain on the treadmill (þ170 seconds, þ104 seconds, þ17 seconds, respectively). The supervised treadmill exercise group improved their 6-minute walk distance by 15 meters, the home-based exercise group improved their 6-minute walk by 45 meters, and the control group improved by 4 meters.
Participants randomized to supervised treadmill exercise had significantly greater improvement in treadmill walking compared with home-based exercise. Participants randomized to home-based exercise had greater improvement in 6-minute walk compared with those randomized to supervised exercise.
The 6-minute walk (primary outcome) increased by 42.4 meters in the intervention group and declined by 11.1 meters in the control group at 6-month follow-up. In addition, the intervention group increased maximal treadmill walking time by 1.01 minutes compared with the control group and increased the Walking Impairment Questionnaire distance and speed scores by 11.1 and 10.4 points, respectively, relative to the control group.
Benefits in the intervention group regarding improved 6-minute walk were attenuated but remained statistically significantly better than the control group at 12-month follow-up, 6 months after the final intervention on-site visit.
Participants randomized to the intervention increased their maximal treadmill walking distance by 24.5 meters, and those randomized to the attention control group increased their maximal treadmill walking distance by 39.2 meters.
An eligibility criterion included the intention to begin an exercise program in the next 6 months, which may have resulted in greater improvement in the control group than otherwise anticipated. Table I . Continued.
walking test). 27 Because corridor walking more closely simulates over-ground walking, home-based exercise programs may have an advantage over supervised treadmill exercise programs with regard to improving walking in daily life for people with PAD. A third randomized trial of home-based exercise, the Group Oriented Arterial Leg Study (GOALS), tested the ability of a group-mediated cognitive-behavioral (GMCB) intervention to help patients with PAD adhere to a home-based walking exercise program, thereby improving their walking performance. 25 The GOALS trial is the only randomized clinical trial of home-based exercise that enrolled PAD participants both with and without symptoms of intermittent claudication. The GOALS trial randomized 192 participants with PAD to either a GMCB intervention or an attention control group for 6 months. 25 The GMCB intervention employed methods that included social cognitive-behavioral change theory and group support. During the first 6 months of GOALS, PAD participants in the intervention group met weekly at the medical center with other PAD patients and a facilitator. The facilitator led discussions regarding goal setting, self-monitoring, and overcoming obstacles to exercise adherence. At 6-month follow-up, participants in the GMCB home-based exercise intervention group significantly improved their 6-minute walk performance (primary outcome measure), pain-free treadmill walking time, and maximum treadmill walking time relative to the control group (Table I) . The intervention group had a 53.5-meter greater increase in 6-minute walk performance, a 1.01-minute greater increase in maximal treadmill walking time, and a 1.02-minute greater increase in pain-free treadmill walking time than the control group. The GMCB home-based exercise intervention also significantly improved physical activity levels and the Walking Impairment Questionnaire distance score compared with the control group. After the 6 months of weekly on-site sessions, between months 7 and 12 after randomization, participants in the GOALS intervention received telephone calls from the facilitator weekly, biweekly, and then monthly. The benefits of the GMCB home-based exercise intervention on 6-minute walk persisted at 12-month follow-up, 6 months after the final on-site study intervention. 27 Participants randomized to the GMCB intervention were also less likely to experience mobility loss, defined as becoming unable either to walk up and down a flight of stairs or to walk a quarter-mile at 6-month and at 12-month follow-up compared with the control group. 28 Among participants without mobility impairment at baseline, rates of mobility loss were 6.3% in the GMCB intervention group vs 26.5% in the control group at 6-month follow-up. Among those without mobility impairment at baseline, rates of mobility loss were 5.2% in the GMCB intervention vs 18.5% in the control group at 12-month follow-up. In addition to being the only randomized trial to study a home-based exercise intervention in PAD participants both with and without intermittent claudication, GOALS is the longest randomized trial to demonstrate benefits of home-based exercise in patients with PAD. However, a fourth randomized trial of home-based exercise demonstrated no benefit of home-based walking exercise in patients with PAD. 29 Collins et al randomized 145 participants with PAD and diabetes to a behavioral intervention vs an attention control group for 6 months. The behavioral intervention consisted of an individualized counseling session at baseline, followed by one walking session per week with an instructor and other patients with PAD at an exercise center and 3 days of walking at home, working up to 50 minutes of exercise per session. Participants in the intervention also received biweekly telephone calls, in which an instructor reviewed their walking progress and provided feedback. The attention control group received biweekly calls from a study investigator during which the participant and study investigator discussed glucose control, blood pressure, and cholesterol levels during the previous month. At 6-month follow-up, there were no differences in treadmill walking performance between the home-based intervention and the control groups (Table I ). The reasons for the lack of efficacy of the home-based walking exercise in this trial are unclear. 29 However, only participants who intended to begin a walking exercise program were eligible and randomized. It is conceivable that even participants in the attention control group began exercising, which may explain the improvement that occurred in each of the two groups.
PRACTICAL ASPECTS OF PRESCRIBING EXERCISE FOR PATIENTS WITH PAD
Before being prescribed a home-based exercise program, PAD patients should complete a baseline treadmill cardiac stress test. 20 The purpose of the stress test is to identify coronary ischemia that may develop during a new walking exercise program. A regular treadmill exercise stress test is sufficient to evaluate most PAD patients for coronary ischemia before initiation of a new exercise program. PAD patients whose baseline treadmill exercise stress test shows no evidence of coronary ischemia may proceed with exercise therapy. PAD patients whose baseline treadmill exercise stress test indicates coronary ischemia should undergo additional evaluation and treatment before initiating an exercise intervention.
Implementing a supervised treadmill exercise program. In a supervised treadmill exercise program, patients with PAD walk for exercise in a supervised setting at least three times weekly (Table II) . The exercise program should be tailored to the individual patient. PAD patients starting an exercise program for the first time often need to begin with just 10 minutes of walking exercise per exercise session. Based on current evidence, PAD patients should be advised to walk to nearly maximal leg pain, although some preliminary evidence suggests that walking only to the onset of ischemic leg pain may also be beneficial. 16 Patients with PAD should be advised to walk at a speed that elicits leg ischemia symptoms within 10 minutes. They should be advised that stopping to rest is acceptable and typical for patients with PAD. Once leg pain subsides during a rest, the PAD patient should be advised to resume walking again. Many patients with PAD may start with just 10 to 15 minutes of walking exercise per session, and the duration of exercise should be increased by 5 minutes each week, until the PAD patient is walking at least 30 minutes per session. Participants able to walk more than 30 minutes per session should be encouraged to increase their walking exercise duration up to 45 to 50 minutes per session. Patients with PAD should be reminded that it is acceptable to stop and rest as necessary in response to ischemic leg pain. Patients who are able to walk continuously for exercise for 10 minutes or more without stopping to rest should have the intensity of the treadmill exercise increased, either by increasing the treadmill speed or by increasing the treadmill grade.
Implementing a home-based walking exercise. Growing evidence demonstrates that home-based exercise improves walking performance in patients with PAD. Clinical practice guidelines state that home-based exercise is a reasonable intervention for patients with PAD who do not have access to a supervised exercise program. 14, 30 Advantages of home-based exercise include that it is less burdensome and more convenient for people with PAD to Home-based exercise programs that have been effective for PAD patients have used activity monitors and incorporated principles of behavioral change theory. Behavioral change methods include goal setting, monitoring of progress, and presence of a "coach" to whom the patient reports on progress (Table II) . Patients with PAD engaged in home-based exercise should be advised to write down walking exercise goals and to record their walking exercise activity each week. This information should be reviewed periodically by a coach or a clinician who can provide feedback to the patient. Successful home-based programs have incorporated coach contact with the participant as infrequently as monthly. 24 
ALTERNATIVE EXERCISE STRATEGIES FOR PAD
Upper and lower extremity ergometry for PAD. Few exercise modalities other than walking exercise have been extensively studied in people with PAD. However, upper and lower limb ergometry has been shown to improve walking performance in people with PAD and intermittent claudication in several randomized trials (Table III) . [33] [34] [35] For example, Zwierska et al 33 randomized
104 participants with PAD into an upper limb aerobic ergometry intervention, a lower limb aerobic ergometry intervention, or a nonexercise control group for 6 months. The exercise interventions took place twice per week and consisted of 2 minutes of arm (or leg) cranking ergometry exercise followed by 2 minutes of rest for a total of 10 cycles (ie, 20 minutes of exercise at each session). At 6-month follow-up, the maximal walking distance, measured by a shuttle-walk protocol, increased by 29% in the upper limb ergometry group and by 31% in the lower limb ergometry group. Peak oxygen uptake also improved in the two exercise groups, suggesting that improved cardiovascular fitness may have contributed to the improved walking endurance. Subsequent randomized trials have also demonstrated benefit of upper and lower extremity ergometry as important exercise modes for people with PAD.
34,35
Resistance training for PAD. Lower extremity resistance training has been evaluated in several randomized clinical trials of participants with PAD (Table III) . 17, 36, 37 Two randomized trials demonstrated significant improvement in maximal treadmill walking time after 6 months of strength training interventions. 17, 36 In the largest trial of resistance training for PAD, 156 participants with PAD were randomized to supervised treadmill exercise, supervised resistance training, or a control group for 6 months. At 6-month follow-up, supervised treadmill exercise achieved a statistically significant and clinically meaningful improvement in 6-minute walk performance, whereas supervised lower extremity resistance training did not achieve significantly greater improvement in 6-minute walk performance than an attention control group (þ35.9 meters vs attention control and þ12.4 meters vs attention control, respectively). 17 Nonetheless, improvements in maximal treadmill walking distance were significantly better in both the supervised treadmill exercise group (þ3.44 minutes; 95% confidence interval, 2.05-4.84 minutes) and the supervised resistance training group (þ1.90 minutes; 95% confidence interval, 0.49-3.31 minutes) compared with the attention control group. Collectively, these data suggest that lower extremity resistance training may improve walking endurance as measured by maximal treadmill walking distance.
CONCLUSIONS
Clinical trial evidence consistently demonstrates that supervised treadmill exercise significantly improves treadmill walking performance in people with PAD. Home-based walking exercise is also beneficial for patients with PAD and improves corridor walking, such as the 6-minute walk test, to a greater degree than treadmill walking exercise. By providing coverage for supervised treadmill exercise, this effective therapy is expected to be accessible to many more patients with PAD in the United States. However, home-based walking exercise may be an alternative therapeutic option for individuals who find traveling for supervised exercise too burdensome.
